STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 116 filers reported holding STOKE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.73 and the average weighting 1.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 10,843,681 | $146,498,130 | 99.89% |
| Lynx1 Capital Management LP | 5,185,191 | $70,051,931 | 25.27% |
| Redmile Group, LLC | 4,721,054 | $63,781,440 | 3.86% |
| Birchview Capital, LP | 210,000 | $2,837,100 | 2.63% |
| COWEN AND COMPANY, LLC | 3,365,744 | $45,471,201 | 1.25% |
| Logos Global Management LP | 1,050,000 | $14,185,500 | 1.15% |
| RTW INVESTMENTS, LP | 4,224,838 | $57,077,561 | 0.88% |
| Baker Brothers Advisors | 4,368,443 | $59,017,665 | 0.75% |
| DAFNA Capital Management LLC | 207,427 | $2,802,339 | 0.67% |
| Sio Capital Management, LLC | 175,301 | $2,368,317 | 0.64% |